Rare Solutions: Advanced Trials for Complex Therapies

Explore how Ergomed successfully managed a Phase III Clinical Trial for Super-Refractory Status Epilepticus (SRSE), a rare and life-threatening CNS disorder.

 
This case study highlights our strategic approach to tackling the challenges of SRSE trials, from securing a diverse patient group across continents to ensuring high-quality data collection in critical care settings. See how Ergomed’s flexible solutions and dedicated support advanced knowledge in SRSE treatment, laying groundwork for future therapies. Download the full case study to learn how Ergomed drives success in rare and complex clinical trials.  

Please fill out the form to view the content

"*" indicates required fields

Please enter your details to get access to the resource

By submitting this form, you consent to your personal data submitted in the form being processed in alignment with our Online Privacy and Cookies policy. Your personal data will be processed to facilitate your request and may be used for sending you additional marketing and business development-related information about Ergomed, its affiliates, and our services. You can withdraw your consent anytime by messaging marketing@ergomedgroup.com, and we will promptly remove your data from our records. For more information about how we will process your personal data and your rights, please see our Online Privacy and Cookies policy.
This field is for validation purposes and should be left unchanged.